Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug combo aims to tackle obesity in major trial

NCT ID NCT07589608

Disease control Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This Phase 2b trial is testing whether two experimental drugs, macupatide and eloralintide, can help adults with obesity or overweight lose weight. About 400 participants will receive either one or both drugs or a placebo for 64 weeks. The study measures weight change and safety, excluding people with diabetes or certain heart conditions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
macupatide and eloralintide (injectable drugs)
What this could lead to
If successful, this could lead to a new combination treatment for significant weight loss in people with obesity or overweight.
What could go wrong
This is a Phase 2 trial, so it's still early. The drugs may not work better than placebo, or they could have side effects like heart rhythm issues or pancreatitis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * See Master Protocol CWMM (NCT06143956) for inclusion criteria Exclusion Criteria: In addition to exclusion criteria in Master Protocol CWMM (NCT06143956): * Have type 1 diabetes or type 2 diabetes * Have an ongoing history of bradyarrhythmia and/or sinus bradycardia * Have an elevated resting pulse rate (greater than 100 bpm) or reduced resting pulse rate (less than 60 bpm) * Have a history of acute or chronic pancreatitis * All concomitant medications should be at a stable dose for at least 3 months prior to screening

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obesity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obesity Overweight

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    40 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division

    RECRUITING

    Troy, Michigan, 48098, United States

  • CTI Clinical Research Center

    RECRUITING

    Cincinnati, Ohio, 45212, United States

  • Central Washington Health Services Association d/b/a Confluence Health

    RECRUITING

    Wenatchee, Washington, 98801, United States

  • Charter Research - Lady Lake

    RECRUITING

    The Villages, Florida, 32162, United States

  • Charter Research - Winter Park

    RECRUITING

    Orlando, Florida, 32803, United States

  • Clinvest Headlands Llc

    RECRUITING

    Springfield, Missouri, 65807, United States

  • Cotton O'Neil Diabetes & Endocrinology

    RECRUITING

    Topeka, Kansas, 66606, United States

  • Dent Neurologic Institute

    RECRUITING

    Amherst, New York, 14226, United States

  • Diablo Clinical Research, Inc.

    RECRUITING

    Walnut Creek, California, 94598, United States

  • Endeavor Clinical Trials

    RECRUITING

    San Antonio, Texas, 78240, United States

  • FutureSearch Trials of Dallas

    RECRUITING

    Dallas, Texas, 75251, United States

  • Great Lakes Clinical Trials - Ravenswood

    RECRUITING

    Chicago, Illinois, 60640, United States

  • Headlands Research - Detroit

    RECRUITING

    Southfield, Michigan, 48034, United States

  • Headlands Research - Scottsdale

    RECRUITING

    Scottsdale, Arizona, 85260, United States

  • IMA Clinical Research Austin

    RECRUITING

    Austin, Texas, 78745, United States

  • Indago Research & Health Center, Inc

    RECRUITING

    Miami Lakes, Florida, 33016, United States

  • Knownwell

    RECRUITING

    Needham, Massachusetts, 02492, United States

  • Las Vegas Medical Research

    RECRUITING

    Las Vegas, Nevada, 89128, United States

  • Lucas Research, Inc

    RECRUITING

    Morehead City, North Carolina, 28557, United States

  • Lucas Research, Inc.

    RECRUITING

    New Bern, North Carolina, 28562, United States

  • Lucida Clinical Trials

    RECRUITING

    New Bedford, Massachusetts, 02740, United States

  • Medical Research Partners

    RECRUITING

    Ammon, Idaho, 83406, United States

  • Medication Management

    RECRUITING

    Greensboro, North Carolina, 27405, United States

  • Monroe Biomedical Research

    RECRUITING

    Monroe, North Carolina, 28112, United States

  • Monroe Biomedical Research - Louisville

    RECRUITING

    Louisville, Kentucky, 40213, United States

  • New Horizon Research Center

    RECRUITING

    Miami, Florida, 33165, United States

  • NorCal Medical Research, Inc

    RECRUITING

    Greenbrae, California, 94904, United States

  • Peninsula Research Associates

    RECRUITING

    Rolling Hills Estates, California, 90274, United States

  • PlanIt Research, PLLC

    RECRUITING

    Houston, Texas, 77079, United States

  • Quality Medical Research

    RECRUITING

    Nashville, Tennessee, 37211, United States

  • Rochester Clinical Research, LLC

    RECRUITING

    Rochester, New York, 14609, United States

  • Sovah Clinical Research-River District

    RECRUITING

    Danville, Virginia, 24541, United States

  • Stamford Therapeutics Consortium

    RECRUITING

    Stamford, Connecticut, 06905, United States

  • StudyMetrix Research

    RECRUITING

    City of Saint Peters, Missouri, 63303, United States

  • Suncoast Clinical Research, Inc.

    RECRUITING

    New Port Richey, Florida, 34652, United States

  • Texas Valley Clinical Research

    RECRUITING

    Weslaco, Texas, 78596, United States

  • The Institute for Liver Health II dba Arizona Clinical Trials - Mesa

    RECRUITING

    Chandler, Arizona, 85225, United States

  • The Institute for Liver Health II dba Arizona Liver Health-Tucson

    RECRUITING

    Tucson, Arizona, 85712, United States

  • Tribe Clinical Research, LLC

    RECRUITING

    Greenville, South Carolina, 29607, United States

  • Velocity Clinical Research, Huntington Park

    RECRUITING

    Huntington Park, California, 90255, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.